Amended and Restated Severance and Change of Control AgreementControl Agreement • May 7th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
This Amended and Restated Severance and Change of Control Agreement (the “Agreement”) is made and entered into, effective as of March 23, 2020 (the “Effective Date”), by and between CytomX Therapeutics, Inc. a Delaware corporation (the “Company”), and Carlos Campoy (“Employee”).
COLLABORATION AND LICENSE AGREEMENT by and between CYTOMX THERAPEUTICS, inc. and ASTELLAS PHARMA INC. Dated as of March 23, 2020Collaboration and License Agreement • May 7th, 2020 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • New York
This Collaboration and License Agreement (“Agreement”) is entered into as of March 23, 2020 (the “Effective Date”) by and between CytomX Therapeutics, Inc., organized and existing under the laws of Delaware with its principal place of business at 151 Oyster Point Blvd., Suite 400, South San Francisco, California 94080, U.S.A. (“CytomX”) and Astellas Pharma Inc., a corporation organized and existing under the laws of Japan with its principal place of business at 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo 103-8411, Japan (“Astellas”). CytomX and Astellas are each hereafter referred to individually as a “Party” and together as the “Parties”.
